Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.60 |
| ▸ | HTR2C | P28335 | 5/20 | 0.60 |
| ▸ | SIGMAR1 | Q99720 | 11/20 | 0.49 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18911620 | 1.00 | HTR2A (0.60) | HTR2AHTR2CSIGMAR1NOTUMHTR1A | |
| SCHEMBL29548539 | 0.98 | HTR2A (0.62) | HTR2AHTR2CSIGMAR1NOTUMHTR1A | |
| SCHEMBL669577 | 0.98 | HTR2A (0.62) | HTR2AHTR2CSIGMAR1NOTUMHTR1A | |
| SCHEMBL30703022 | 0.92 | HTR2A (0.64) | HTR2AHTR2CSIGMAR1NOTUMHTR1A | |
| SCHEMBL761931 | 0.92 | HTR2A (0.64) | HTR2AHTR2CSIGMAR1NOTUMHTR1A | |
| Acetic Acid SCHEMBL13279290 | 0.87 | HTR2A (0.55) | HTR2AHTR2CSIGMAR1 | |
| SCHEMBL18911621 | 0.84 | HTR2A (0.73) | HTR2AHTR2CSIGMAR1NOTUMHTR1A | |
| SCHEMBL7512405 | 0.76 | KMT2A (0.54) | NOTUMPOLB | |
| SCHEMBL24916793 | 0.75 | SIGMAR1 (0.50) | HTR2AHTR2CSIGMAR1 | |
| SCHEMBL6711152 | 0.75 | HTR2A (1.00) | HTR2AHTR2CSIGMAR1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017088746-A1 | NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR AND APPLICATION THEREOF | 南京圣和药业股份有限公司 | 2017-06-01 | — | — | WO | disclosed |
| US-5721245-A | ANTIINFLAMMATORY AGENTS, RESPIRATORY SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1998-02-24 | — | — | US | disclosed |
| EP-0384349-B1 | Substituted pyrroles | HOFFMANN LA ROCHE (CH) | 1994-04-27 | — | — | EP | disclosed |
| US-5026696-A | Psychotic disorders, anziety, nausea and vomiting | GLAXO GROUP LIMITED (GB) | 1991-06-25 | — | — | US | disclosed |
| US-4963546-A | Ketone derivatives which are antagonists of 5-HT at 5-HT3 receptors, compositions containing them, and method of use | GLAXO GROUP LIMITED (GB) | 1990-10-16 | — | — | US | disclosed |
| EP-0384349-A1 | Substituted pyrroles | F. HOFFMANN-LA ROCHE AG (CH) | 1990-08-29 | — | — | EP | disclosed |
| EP-0327307-A2 | Tricyclic ketone derivatives having a 5-HT3 antagonist activity | GLAXO GROUP LIMITED (GB) | 1989-08-09 | — | — | EP | disclosed |